baber/WOPTO huggingface dataset:
Patent CA-2812595-A1 (CA)
Inventor: HOLVERSON TODD E
IPC: G07C1/10
Filed: 2011-10-07
Abstract: An apparatus for monitoring weld cell (104) of a welding system (100) and related activity is disclosed. The activity is sensed using a variety of sensors (106, 108, 110, 112, 114, 116), and reported to the controller (102), or to a remote location.
Patent CA-2814603-A1 (CA)
Title: Metal profile with thermal break
Inventor: GOSSELIN PIERRE
IPC: E06B3/12
Filed: 2013-05-01
Abstract: The present relates to a metal profile having a thermal break for making doors. The metal profile comprises two complementary metal structural members. The two complementary metal structural members define at least one junction area there between, where each junction area defines a channel between the two complementary metal structural members. The metal profile further comprises a structural adhesive material for filling each of the channel. The structural adhesive material simultaneously forms a mechanical joint and a thermal break between the two complementary metal structural members. The structural adhesive material has a low thermal conductivity, a high percentage of elongation, and maintains a high rigidity of the metal profile.  In an embodiment, the two structural members are made of aluminum.
Patent CA-2815422-A1 (CA)
Inventor: KESELOWSKY BENJAMIN GEORGE
IPC: A61P3/10
Filed: 2011-10-24
Abstract: The present invention provides antigen-specific, tolerance-inducing microparticles for the targeted delivery of therapeutic agents to immune cells. In addition, the present invention allows for sustained release of therapeutic agents for a prolonged period of time. Also provided are therapeutic uses of the present invention for the prevention and/or treatment of immune diseases and autoimmune disorders. In a specific embodiment, the present invention provides treatment for type 1 diabetes.
Patent CA-2815613-A1 (CA)
Title: Dispositif d'inversion de poussee sans bielle dans la veine
Inventor: HURLIN HERVE
IPC: F02K1/72
Filed: 2011-10-25
Abstract: La présente invention se rapporte à une nacelle (l)de turboréacteur équipée d'au moins un dispositif d'inversion de poussée comprenant, d'une part, des moyens de déviation (41), et d'autre part, au moins un capot mobile (30) en translation selon une direction sensiblement parallèle à un axe longitudinal de la nacelle entre une position de fermeture dans laquelle il assure la continuité aérodynamique de la nacelle et couvre les moyens de déviation et une position d'ouverture dans laquelle il ouvre un passage dans la nacelle et découvre les moyens de déviation, le dispositif d'inversion de poussée comprenant par ailleurs, au moins un volet de blocage (60) monté pivotant par au moins une extrémité rattachée à une partie arrière des moyens de déviation, caractérisée en ce que l'extrémité de pivotement est liée à la partie arrière des moyens de déviation également de manière translatable.
Patent CA-2815888-A1 (CA)
Inventor: HUSSACK GREG
IPC: C07K16/12
Filed: 2011-10-25
Abstract: The present invention is directed to Clostridium difficile toxin-specific antibodies, compositions, and uses thereof. The anti-toxin antibodies may be specific for either TcdA or TcdB. The invention also includes methods of treating a Clostridium difficile infection, methods of capturing Clostridium difficile toxins, and methods of detecting Clostridium difficile toxins.
Patent CA-2816265-A1 (CA)
Inventor: KIANI MEHRDAD
IPC: A61B1/267
Filed: 2013-05-08
Abstract: The claimed invention assists in endotracheal intubation of patients both orally and nasally. This is a bougie with handle adjustability in which a smartphone is used as displaying, imaging and recording unit. In addition to providing direct and digital view of the patients airway anatomy, this unit enables the user to store the images and video of intubation procedure in the smartphone memory for consultation, research and teaching purposes. The claimed device has a bending mechanism which gives the stylet or bougie the controllability of a flexible fiberoptic bronchoscope, while it has less weight;  less complexity: and it has much less price compared to a flexible fiberoptic bronchoscope. It can be used for both out of hospital case scenarios (e.g., ambulances and first responders in fire department vehicles) and intra-hospital cases (e.g., emergency rooms, ICU and operation rooms).
Patent CA-2819423-A1 (CA)
Inventor: BUNDOCK PAUL
IPC: C12N15/10
Filed: 2011-11-25
Abstract: The current invention relates to a method for targeted alteration of acceptor DNA, for example duplex acceptor DNA. The method comprises the use of an oligonucleotide having at least one mismatch relative to the targeted (duplex) acceptor DNA. The mismatch is located at specific positions within said oligonucleotide. Also provided is a kit that comprises instructions for performing the method according to the inventions, and in a preferred embodiment, comprises an oligonucleotide suitable for use in the method.
Patent CA-2822701-A1 (CA)
Inventor: DEMARINI DOUGLAS J
IPC: A61K31/519
Filed: 2011-12-20
Abstract: Disclosed are novel pharmaceutical compositions containing N-{3-[3- cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7- tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide dimethyl sulfoxide solvate, methods of using the compositions in therapy and processes for preparing the same.
Patent CA-2822871-A1 (CA)
Title: Footwear for use in specialized activities
Inventor: MACPHAIL DAVID MICHAEL
IPC: A61F5/14
Filed: 2012-12-12
Abstract: Footwear for use during a specialized activity such as skiing, cycling, skating and many other sports or industrial uses, and provides a dorsal element engaging the dorsal aspect of the foot for enabling the user to control relative to the plantar aspect the maximum height of the arch of the foot at substantially ail times during the activity regardless of the position or orientation of the foot. A  pivotal arm is mounted on a frame attached to the planter aspect for pivotal movement about an axis transverse to the foot and is compressed by an adjustable element operable by the user.
Patent CA-2822895-A1 (CA)
Inventor: YANG CHIN-FEN
IPC: C12Q1/68
Filed: 2005-05-20
Abstract: Polypeptides, polynucleotides, methods, compositions, and vaccines comprising (avian pandemic) influenza hemagglutinin and neuraminidase variants are provided. Specifically, the invention relates to a 6:2 reassortant influenza virus which comprises a genome segment encoding an HA polypeptide comprising the amino acid sequence of SEQ ID NO:15.
Patent CA-2824089-A1 (CA)
Inventor: TOTORITIS MARK
IPC: A61K33/242
Filed: 2012-02-02
Abstract: The invention relates to methods of selecting a subject, and methods of treating the subject with an anti-VLA-l antibody. In one embodiment the first therapeutic agent is a DMARD (Disease Modifying Antirheumatic Drug), such as gold salts; hydroxychloroquine; an antifolate, such as methotrexate; a pynmidine synthesis inhibitor, such as leflunomide; or a sulfa drug, such as sulfasalazine. For example, the DMARD can be methotrexate, administered at a dose of mg/week or less; leflunomide, administered at a dose of 20 mg/day or less; sulfasalazine, administered at a dose of 3000 mg/day or less; or hydroxychloroquine, administered at a dose of 400 mg/day or less.
Patent CA-2827095-A1 (CA)
Title: Apparatus and methods for treating intracorporeal fluid accumulation
Inventor: DEGEN THOMAS
IPC: G16H40/63
Filed: 2012-02-15
Abstract: A fluid management system (10) for the treatment of ascites, pleural effusion or pericardial effusion is provided including an implantable device (20) including a pump (95), control circuitry (70), battery (74) and transceiver (76); a charging and communication system (30) configured to periodically charge the battery and communicate with the implantable device to retrieve performance data; and monitoring and control (40) software, suitable for use with conventional personal computers, for configuring and controlling operation of the implantable device and charging and communication system. The implantable device includes a number of features that provide automated movement of fluid to the bladder with reduced risk of clogging, with no patient involvement other than occasional recharging of the battery of the implantable device. The monitoring and control software is available only to the treating physician, such that the physician interacts with the implantable device via the charging and communication system.
Patent CA-2827638-A1 (CA)
Title: Reservoir
Inventor: MULLEN DAVID
IPC: B65D88/08
Filed: 2013-09-17
Abstract: A reservoir with a foundation formed from ground-engaging segments which surround a base, interengaged vertical wall elements which are mounted to the segments, fasteners which fix the elements to the segments, and a liner which extends over the base and opposed inner surfaces of the elements.
Patent CA-2828383-A1 (CA)
Title: Procede de suppression du decollement tournant dans une turbomachine
Inventor: DJELASSI CEDRIK
IPC: F04D27/02
Filed: 2012-02-28
Abstract: L'invention concerne un procédé de suppression d'un décollement tournant dans un compresseur d'une turbomachine, caractérisé en ce qu'il comporte les étapes suivantes : - Une étape (103) de détection automatique d'un pompage dans la turbomachine; - Une étape (104) d'extinction automatique de la turbomachine; - En cas de détection d'un pompage, une étape (106) de restitution automatique d'une marge au pompage; - Une étape (105) de rallumage automatique de la turbomachine.
Patent CA-2828544-A1 (CA)
Inventor: FEINSTEIN ELENA
IPC: C12N15/113
Filed: 2012-03-01
Abstract: La présente invention se rapporte à des molécules d'acide nucléique double brin et à des compositions pharmaceutiques les contenant. Les molécules d'acide nucléique double brin et les compositions pharmaceutiques selon l'invention sont utiles dans le traitement, entre autres, d'inflammations aiguës et chroniques, de douleurs neuropathiques, d'un dysfonctionnement du greffon primaire (PGD, Primary Graft Dysfunction) après une transplantation pulmonaire chez un sujet en ayant besoin. Les composés sont de préférence des composés ARN à double brin modifiés et synthétisés chimiquement, qui régulent à la baisse ou inhibent l'expression des gènes d'un récepteur de type Toll.
Patent CA-2830048-A1 (CA)
Inventor: LOPEZ CARLOS
IPC: G06Q30/04
Filed: 2013-10-09
Abstract: Large volumes of financial transactions are processed today across a variety of financial platforms including but not limited to debit cards, credit cards, prepaid cards, e-purse, Automatic Teller Machine (ATM) transactions, and Point of Sale (POS) cards. It would be beneficial if financial transaction software systems and / or software applications supported discrete and periodic transactions wherein the timescales of transactions may be established with high flexibility. It would be further of benefit if the financial system provided increased security such that customer specific financial data is stored within a trusted platform wherein external databases identifying a customer cannot be linked directly to that within the trusted platform. Further it would beneficial for such a system to exploit an encryption key pool such that an encryption key employed was only identified through a unique identity and that said encryption keys within the pool may be expired with arbitrary policies.
Patent CA-2831600-A1 (CA)
Title: Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
Inventor: RANE SUPRIYA
IPC: A61K31/137
Filed: 2012-03-30
Abstract: A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.
Patent CA-2833939-A1 (CA)
Inventor: GRIFFITHS PHILIP MORGAN
IPC: A47F3/00
Filed: 2012-06-18
Abstract: A merchandising unit (10) for consumer goods comprising: a support unit (12) comprising connecting means for mounting the merchandising unit on a support surface and at least one hinged support arm (20,22) extending from the connecting means and moveable relative to the connecting means between a first position and a second position; and a housing (14) for housing the consumer goods. The housing (14) is mounted on the at least one hinged support arm (20,22) for movement relative to the at least one hinged support arm between a closed position, in which at least some of the consumer goods are not visible, and an open position in which at least some of the consumer goods that are not visible in the closed position are visible.
Patent CA-2834806-A1 (CA)
Title: Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same
Inventor: BADEA ILDIKO
IPC: A61P35/00
Filed: 2012-05-18
Abstract: This disclosure relates to cyclodextrin-based drug delivery agents that comprise a cyclodextrin moiety covalently linked to a moiety of a gemini surfactant. Pharmaceutical compositions comprising the drug delivery agent and a therapeutic agent are also disclosed.
Patent CA-2837966-A1 (CA)
Inventor: SIROVICH JAIMIE
IPC: G06F17/30
Filed: 2012-05-30
Abstract: The present invention is a system to permit access to document result pages on a domain or subdomain using a domain or a subdomain URL with a search engine, a user defined list that is utilized to enable any document result pages visibility and a first component that saves and transfers the document result pages to a web server. Web search engines may address the document result pages exactly as a human does, using the same URLs, on any desired domain or subdomain, including the main web site domain. There is also a second component where the document result pages are manually transferred to the web server and a plurality of browser based scripts that are inserted into the website HTML text to update the browser's displayed URL to a corresponding URL that accesses a particular document result page that is transferred to the web server.
Patent CA-2838524-A1 (CA)
Title: Circular stapling instrument
Inventor: PENNA CHRISTOPHER
IPC: A61B17/32
Filed: 2014-01-08
Abstract: A circular stapling instrument including a stapling forming assembly that is actuated independently from actuation of the cutting assembly is provided. The instrument includes a handle assembly, an elongate body extending from the handle assembly, a cartridge assembly mounted on a distal end of the elongate body. The cartridge assembly includes a pusher assembly and a knife assembly. The knife assembly is selectively fixed relative to the pusher assembly.
Patent CA-2840020-A1 (CA)
Inventor: HAMADA SHIGETAKA
IPC: H01M8/10
Filed: 2011-07-05
Abstract: Provided is a fuel cell, the output voltage of which is improved by making a membrane moist state uniform. An anode-side gas diffusion layer (12) and a cathode-side gas diffusion layer (14) are joined to a membrane electrode assembly (10), and a separator (20) is joined to the anode-side gas diffusion layer (12).  The separator (20) has a recess portion (22) and a protrusion portion (24) formed to constitute a gas flow path and a refrigerant flow path, respectively. The cross-sectional area of the recess portion (22) is made relatively small at the downstream side in comparison with that at the upstream side, and the cross-sectional area of the protrusion portion (24) is made relatively large at the downstream side in comparison with that at the upstream side, thereby improving the moist state.
Patent CA-2840184-A1 (CA)
Title: Methode de regulation de la puissance d'une installation de conversion d'energie et installation de conversion d'energie pilotee par une telle methode
Inventor: BATS GUILLAUME
IPC: H02P9/42
Filed: 2012-06-22
Abstract: Cette méthode permet de réguler de la puissance d'une installation (100) de conversion d'énergie mécanique en énergie électrique. L'installation (100) comprend une machine (1), un alternateur (2), un premier convertisseur (41), un câble électrique (3) qui relie les bornes de l'alternateur (2) au premier convertisseur (41), un second convertisseur (42), des moyens de mesure (8, 41, 43), une unité de commande (5), le premier convertisseur (41) modulant la fréquence et le courant du premier signal électrique (S2). La méthode comprend une première étape préalable dans laquelle la valeur d'une première grandeur proportionnelle à une puissance réactive est implémentée dans l'unité de commande et une étape principale dans laquelle l'unité de commande (5) détermine la fréquence de pilotage et le courant de pilotage à partir d'une erreur égale à la différence entre la première grandeur et une seconde grandeur qui est à la fois homogène à la première grandeur, fonction de la puissance réactive du premier convertisseur (41) et déterminée à partir d'une valeur mesurée du courant du premier signal électrique (S2).
Patent CA-2841773-A1 (CA)
Inventor: REICHERT CRAIG STEVEN
IPC: A47F3/04
Filed: 2012-07-02
Abstract: A door for a refrigerated merchandiser including a case that defines a product display area. The door includes a frame and a first glass pane coupled to the frame. The first glass pane has heat-absorbing glass and is configured to be positioned adjacent an ambient environment surrounding the refrigerated merchandiser to absorb radiation from the ambient environment. The door also includes a second glass pane coupled to the frame and configured to be positioned adjacent the product display area. The second glass pane includes a conductive coating. The door further includes a third glass pane positioned between and spaced from the first glass pane and the second glass pane, and has a low emissivity coating.
Patent CA-2842099-A1 (CA)
Title: Antigen binding constructs
Inventor: ASHMAN CLAIRE
IPC: C07K16/22
Filed: 2012-07-25
Abstract: The present invention is directed to antigen binding constructs comprising one or two epitope binding domains separated by a single chain Fc region of an antibody, wherein each epitope binding domain in capable of binding to VEGF, to dimers comprising two antigen binding constructs of the invention, pharmaceutical compositions comprising said dimers and their use in the treatment of diseases associated with VEGF signalling, such as diabetic macular edema (DME), wet age-related macular degeneration (Wet AMD), diabetic retinopathy, retinal vein occlusion (RVO), and corneal neovascularisation, and polynucleotide sequences encoding said antigen binding constructs.
Patent CA-2842305-A1 (CA)
Title: Terminal, base station, communications system, and communication method
Inventor: NOGAMI TOSHIZO
IPC: H04W28/04
Filed: 2012-07-19
Abstract: A terminal that communicates with a base station monitors a physical downlink control channel allocated in a physical downlink control channel region and an enhanced physical downlink control channel allocated in a physical downlink shared channel region different from the physical downlink control channel region. If the enhanced physical downlink control channel is detected, the terminal reports response information via a physical uplink control channel resource corresponding to the resource in which the enhanced physical downlink control channel was detected.
Patent CA-2842462-A1 (CA)
Title: Hydrogel materials incorporating eluting ceragenin compound
Inventor: SAVAGE PAUL B
IPC: A61L31/16
Filed: 2012-07-20
Abstract: A hydrogel polymer includes a ceragenin compound. The ceragenin compound has a hydrophobicity/hydrophilicity that produces a release rate in a range of 0.1-100 µg/ml for at least 3 days.
Patent CA-2846495-A1 (CA)
Title: Positive locking connector coupling
Inventor: GALLUSSER DAVID
IPC: H01R13/639
Filed: 2014-03-12
Abstract: A coupling that includes, a connector body, an interface coupling, a first collar coupled to the interface coupling that has a main body with an inner retaining member including a first set of teeth and a first engagement member, a second collar surrounding the first collar that has at least one second engagement member and is movable axially between a disengaged position when the first and second engagement members are disengaged and an engaged position when the first and second engagement members are engaged, and a ratchet ring that is received inside of the first collar, that has a second set of teeth, and that is axially moveable with respect to the connector body between a locked position when the first and second sets of teeth are engaged and an unlocked position when the first and second sets of teeth are spaced from one another.
Patent CA-2846678-A1 (CA)
Inventor: PUGH RANDALL B
IPC: H05B37/02
Filed: 2014-03-14
Abstract: An energized ophthalmic lens device is disclosed. The energized ophthalmic lens device can include one or more modulated photonic emitters, a media insert supporting a first processor and one or more light sources, and one or more antennas configured to communicate with the first processor and a second processor. The one or more light sources can be configured to generate light. At least a portion of the generated light from the one or more light sources can be emitted by the one or more photonic emitters. The first processor can be configured to receive, from a sensor, an indication to project a visual representation. The processor can further be configured to control, in response to the received indication, at least one of the one of more modulated photonic emitters and the one or more light sources based on one or more programmed parameters.
Patent CA-2846936-A1 (CA)
Title: Method of reforming gasification gas
Inventor: SIMELL PEKKA
IPC: C10K3/02
Filed: 2012-09-03
Abstract: A method of reforming a gasification gas, in order to decompose the impurities comprised in it, and a new use of a precious metalcatalyst in the pre-reforming of gasification gas. In the present method, the gas is brought into contact with a metal catalyst in the presence of an oxidizing agent. According to the present invention, the reformation is carried out in several stages, in which case at least in one of the first catalytic zones a noble metal catalyst is used, and in a secondary reforming stage which follows the first, preliminary reforming zone,the catalyst used is a metal catalyst. Oxygen is fed separately into each of the catalyst zones. The use of a noble metalcatalyst reduces the risk of deactivation of the metal catalysts and thus increases the operating life of the catalyst.
Patent CA-2850257-A1 (CA)
Title: Toit de vehicule en verre comprenant des zones locales de contrainte en compression
Inventor: HENNION ALEXANDRE
IPC: B62D25/06
Filed: 2012-10-12
Abstract: L'invention concerne un toit de véhicule automobile comprenant deux bords longitudinaux et deux bords transversaux, symétrique par rapport à un plan longitudinal médian, consistant en un vitrage comprenant au moins une feuille de verre minéral, ladite feuille comprenant une ceinture de contraintes de bords en compression, ladite feuille comprenant au moins deux zones locales de contraintes en compression à l'intérieur de ladite ceinture et placées symétriquement par rapport audit plan de symétrie, chaque zone locale de contraintes en compression étant à moins de 30 cm d'un bord longitudinal.
Patent CA-2853473-A1 (CA)
Inventor: EGGERS MITCHELL
IPC: G06Q50/30
Filed: 2012-10-26
Abstract: A survey data structure is described that specifies how to administer a survey to each of a group of people. The data structure contains an entry that specifies text that poses a fabrication gauge question for which a percentage of the population who can accurately answer the fabrication gauge question affirmatively is known. The data structure further contains a plurality of entries that each specify text posing an unlikely question for which the percentage of the population who can accurately answer the unlikely question affirmatively is small. The data structure specifies how to conduct a survey that serves as a basis for determining which people to whom the survey is administered are responding truthfully to the survey.